TLRY
TLRY
NASDAQ · Pharmaceuticals

Tilray Brands Inc

$2.81
-0.15 (-5.07%)
As of Nov 7, 1:55 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.23B
Net Income
-162,706,958
Gross Margin
28.4%
Profit Margin
-13.3%
Rev Growth
+13.4%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.4% 28.4% 58.9% 58.9%
Operating Margin -6.9% -6.2% 36.6% 37.4%
Profit Margin -13.3% -12.6% 27.4% 25.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.23B 1.08B 180.40M 169.99M
Gross Profit 349.08M 307.72M 106.25M 100.12M
Operating Income -84,417,244 -66,974,188 66.09M 63.51M
Net Income -162,706,958 -129,086,973 49.45M 42.44M
Gross Margin 28.4% 28.4% 58.9% 58.9%
Operating Margin -6.9% -6.2% 36.6% 37.4%
Profit Margin -13.3% -12.6% 27.4% 25.0%
Rev Growth +13.4% +13.4% -1.4% +19.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 37.66M 37.66M 368.43M 383.92M
Total Equity 172.93M 172.93M 614.67M 608.97M
D/E Ratio 0.22 0.22 0.60 0.63
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -58,232,753 -48,766,850 94.91M 94.57M
Free Cash Flow — — 60.57M 46.11M